Insiders · GENB

Michael Nally

Chief Executive Officer, Director at Generate Biomedicines, Inc. (GENB)

Michael Nally has filed 42 insider reports with the SEC since February 2021, as director at Ppg Industries Inc (PPG), chief Executive Officer and director at Generate Biomedicines, Inc. (GENB) and officer at Merck & Co., Inc. (MRK). In the last 12 months Michael Nally bought $240K of stock on the open market. The latest filing, on September 14, 2026, reports grant or award at Ppg Industries Inc (PPG).

Schedule 13D and 13G filings by Michael Nally

Filings
42
Companies
3
Bought on market
$240K
Sold on market
None

Companies where Michael Nally is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Ppg Industries Inc logo
PPG
Ppg Industries Inc
Directorsince February 2021264$122.78Sep 14, 2026
Generate Biomedicines, Inc. logo
GENB
Generate Biomedicines, Inc.
Chief Executive Officer, Director572,707$240K$12.00$10.38-13%Mar 6, 2026
Merck & Co., Inc. logo
MRK
Merck & Co., Inc.
Officer19,630$137.78Mar 2, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Michael Nally with

Other insiders at the same companies

Questions about Michael Nally

What is Michael Nally's role at Generate Biomedicines, Inc.?
Michael Nally reports to the SEC as chief Executive Officer and director at Generate Biomedicines, Inc. (GENB), according to the latest filing on March 6, 2026. Michael Nally has also filed as director at Ppg Industries Inc (PPG) and officer at Merck & Co., Inc. (MRK).
How many shares does Michael Nally own?
After the latest filing that states it, Michael Nally directly owned 264 shares of Ppg Industries Inc (PPG), 572,707 shares of Generate Biomedicines, Inc. (GENB) and 19,630 shares of Merck & Co., Inc. (MRK). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Nally bought or sold stock recently?
The most recent open-market purchase was on March 4, 2026: bought 20,000 shares of Generate Biomedicines, Inc. (GENB) for $240K at an average of $12.00.
How do I get alerts when Michael Nally files?
Follow Michael Nally on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael Nally filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Michael Nally (SEC CIK 0001763945). Totals count each trade once, skipping amendments whose original is on file, from Feb 19, 2021 on. View on SEC EDGAR